Genmab (United States)

Genmab (United States)

Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Genmab (United States), United States, covering academic research published from 2001 to 2024. Read More.


Open Access Percentage

52%


Total
Publications

459


Total Open
Publications

238


Total
Citations

16K


Open Access
Percentage

52%


Total
Publications

459


Total Open
Publications

238


Total
Citations

16K

Wikipedia

Website

download

Breakdown

25% 20% 5% 50%

Publisher Open

25%

Both

20%

Other Platform Open

5%

Closed

50%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090100110Total Publications
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

39%OA Journal

OA Journal 39%

77

Hybrid 29%

58

No Guarantees 32%

65

Other Platform Open

Domain 75%

85

Institution 35%

40

Other Internet 10%

11

Public 2%

2

Preprint 1%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
85
DANS - Data Archiving and Networked Services
Institution
13
University of Southern Denmark - University of Southern Denmark Research Portal
Institution
9
DOI
Other Internet
9
Elsevier - Scopus
Institution
6
Digital Access to Libraries
Institution
6
University of Groningen / Centre for Information Technology - University of Groningen research database
Institution
3
Griffith University, Queensland, Australia - Griffith Research Online
Institution
3
Alma Mater Studiorum Università di Bologna - Archivio istituzionale della ricerca
Institution
3
Utrecht University - Utrecht University Repository
Institution
2
1 / 4

Data updated 18 August 2025

Share

Share

Share